Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is R$ 5.668,27, with a 24-hour trading volume of R$ 0. The asset's market cap is R$ 5,05T, after moving -1.21% in the last day.
Tokenized Eli Lilly And Co is trading at R$ 5.656,48, with a tokenized market cap of R$ 218,99M and a 24-hour trading volume of R$ 13,29M. The tokenized asset has moved -1.12% in the past 24 hours.